We are live on !
Find out more
Point72 (DIFC) Portfolio holdings
AUM
$1.53B
Turnover
69.25%
1-Year Est. Return
15.83%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+15.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.53B
AUM Growth
-$1.12B
(-42%)
Cap. Flow
+$151M
Cap. Flow % of AUM
Cap. Flow %
9.87%
Top 10 Holdings %
Top 10 Hldgs %
24.76%
Holding
1,997
New
503
Increased
228
Reduced
372
Closed
880
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.2
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$44.7M |
| 2 |
Microsoft
MSFT
|
+$41.9M |
| 3 |
Boston Scientific
BSX
|
+$27.2M |
| 4 |
Visa
V
|
+$26.6M |
| 5 |
TSMC
TSM
|
+$25.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$30.4M |
| 2 |
Analog Devices
ADI
|
+$24.4M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$24.4M |
| 4 |
GE Aerospace
GE
|
+$22.9M |
| 5 |
Lam Research
LRCX
|
+$21.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.12% |
| 2 | Technology | 23.11% |
| 3 | Financials | 13.26% |
| 4 | Communication Services | 8.27% |
| 5 | Consumer Discretionary | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1101
Metagenomi Therapeutics
MGX
$29.5M
| $318 | ﹤0.01% |
134
| – | – |
2025 Q2
1 quarter
|
|
1102
Bridger Aerospace
BAER
$24.8M
| $315 | ﹤0.01% |
+170
| New | +$322 |
2025 Q3
0 quarters
|
|
1103
Ovid Therapeutics
OVID
$496M
| $256 | ﹤0.01% |
197
-1,104
| -85% | -$957 |
2025 Q2
1 quarter
|
|
1104
Everspin Technologies
MRAM
$332M
| $223 | ﹤0.01% |
24
-1,076
| -98% | -$7.31K |
2025 Q2
1 quarter
|
|
1105
DELISTED
Flushing Financial
FFIC
| $215 | ﹤0.01% |
+16
| New | +$208 |
2025 Q3
0 quarters
|
|
1106
Pliant Therapeutics
PLRX
$53.2M
| $166 | ﹤0.01% |
112
-6,996
| -98% | -$10.7K |
2025 Q2
1 quarter
|
|
1107
Klarna Group
KLAR
$5.04B
| $156 | ﹤0.01% |
+4
| New | +$171 |
2025 Q3
0 quarters
|
|
1108
DELISTED
iRobot
IRBT
| $101 | ﹤0.01% |
28
-3,933
| -99% | -$15.2K |
2025 Q2
1 quarter
|
|
1109
Neumora Therapeutics
NMRA
$69M
| $93 | ﹤0.01% |
51
-1,068
| -95% | -$1.73K |
2025 Q2
1 quarter
|
|
1110
374Water
SCWO
$43.6M
| $87 | ﹤0.01% |
30
| – | – |
2025 Q2
1 quarter
|
|
1111
Mercer International
MERC
$8.04M
| $86 | ﹤0.01% |
30
| – | – |
2025 Q1
2 quarters
|
|
1112
Caribou Biosciences
CRBU
$45.4M
| $77 | ﹤0.01% |
33
-5,202
| -99% | -$9.8K |
2025 Q1
2 quarters
|
|
1113
Atossa Therapeutics
ATOS
$21.7M
| $71 | ﹤0.01% |
5
-552
| -99% | -$6.82K |
2025 Q2
1 quarter
|
|
1114
Dingdong
DDL
$411M
| $43 | ﹤0.01% |
21
-2,879
| -99% | -$6.24K |
2025 Q2
1 quarter
|
|
1115
Dakota Gold
DC
$680M
| $36 | ﹤0.01% |
8
+2
| +33% | +$8 |
2025 Q2
1 quarter
|
|
1116
Lexicon Pharmaceuticals
LXRX
$632M
| $20 | ﹤0.01% |
15
-6,967
| -100% | -$7.91K |
2025 Q1
2 quarters
|
|
1117
InfuSystem Holdings
INFU
$280M
| $10 | ﹤0.01% |
1
-1,299
| -100% | -$10.8K |
2025 Q2
1 quarter
|
|
1118
CALL
Agilent Technologies
A
$49.3B
| – | – |
-400
| Closed | -$47.2K | – |
|
|
1119
PUT
Agilent Technologies
A
$49.3B
| – | – |
-200
| Closed | -$23.6K | – |
|
1120
ABM Industries
ABM
$3.13B
| – | – |
-1,146
| Closed | -$54.1K | – |
|
1121
Acadia Pharmaceuticals
ACAD
$3.55B
| – | – |
-9,764
| Closed | -$211K | – |
|
1122
Accel Entertainment
ACEL
$922M
| – | – |
-1,088
| Closed | -$12.8K | – |
|
1123
Albertsons Companies
ACI
$6.35B
| – | – |
-195,335
| Closed | -$4.2M | – |
|
1124
ACM Research
ACMR
$3.17B
| – | – |
-1,007
| Closed | -$26.1K | – |
|
1125
CALL
Adobe
ADBE
$97.4B
| – | – |
-2,100
| Closed | -$812K | – |
|
Similar funds
Point72 (DIFC)'s Q3 2025 Portfolio in Review
As of Q3 2025, Point72 (DIFC) held 1,997 positions worth $1.53B, down 42% from $2.64B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Point72 (DIFC) deployed $151M of net new capital in Q3 2025, opening 503 new positions and adding to 228 existing holdings. Its largest new stake was Visa: 76,800 shares worth $26.2M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Analog Devices, an estimated $24.4M trimmed.
- Point72 (DIFC)'s largest Q3 2025 buy was Visa: 76,800 shares worth $26.2M.
- Point72 (DIFC) added most to Meta Platforms (Facebook) in Q3 2025, an estimated $44.7M increase.
- Point72 (DIFC)'s biggest Q3 2025 reduction was Analog Devices, cutting an estimated $24.4M.
- Point72 (DIFC) fully exited NVIDIA in Q3 2025, selling an estimated $30.4M.
- Point72 (DIFC)'s ten largest holdings make up 25% of its $1.53B portfolio in Q3 2025.
- Point72 (DIFC) opened 503 new positions and closed 880 in Q3 2025.
- Point72 (DIFC)'s portfolio value fell 42% quarter-over-quarter to $1.53B.
Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.